Literature DB >> 22302024

Expression of microsomal prostaglandin E synthase-1 in the spinal cord in a transgenic mouse model of amyotrophic lateral sclerosis.

Hiroko Miyagishi1, Yasuhiro Kosuge, Kumiko Ishige, Yoshihisa Ito.   

Abstract

Prostaglandin E(2) (PGE(2)) is a key molecule involved in the neuroinflammatory processes that characterize amyotrophic lateral sclerosis (ALS). Although PGE(2) synthesis is regulated by PGE(2) synthases (PGESs), the pathological role of PGESs in ALS still remains unknown. Experiments were performed to elucidate the expression of PGESs and the localization of microsomal PGES-1 (mPGES-1) in neurons and glial cells in the spinal cord of ALS model (G93A) mice. Neurological symptom was observed in G93A mice from 14 weeks by the tail suspension test, and rotarod performances were decreased at 16 weeks and older. Western blotting revealed that the level of mPGES-1 was increased in G93A mice at 15 weeks and older. In contrast, the levels of cytosolic PGES and mPGES-2 did not change at any age. Immunohistochemical analysis demonstrated that age-dependent expression of mPGES-1 was found in motor neurons in G93A mice at 11 and 15 weeks. Immunoreactivity of mPGES-1 was also co-localized in Iba1-positive microglia in G93A mice at 15 weeks. These results suggest that mPGES-1 in motor neurons may play a role in the pathogenesis of ALS and that mPGES-1 may work sequentially in motor neurons and activated microglia to produce ALS symptoms in G93A mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302024     DOI: 10.1254/jphs.11221fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

1.  Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.

Authors:  Hiroko Miyagishi; Yasuhiro Kosuge; Ayumi Takano; Manami Endo; Hiroshi Nango; Somay Yamagata-Murayama; Dai Hirose; Rui Kano; Yoko Tanaka; Kumiko Ishige; Yoshihisa Ito
Journal:  Cell Mol Neurobiol       Date:  2016-05-02       Impact factor: 5.046

Review 2.  Present State and Future Perspectives of Prostaglandins as a Differentiation Factor in Motor Neurons.

Authors:  Hiroshi Nango; Yasuhiro Kosuge
Journal:  Cell Mol Neurobiol       Date:  2021-05-25       Impact factor: 4.231

3.  A Study to Decipher the Potential Effects of Butylphthalide against Central Nervous System Diseases Based on Network Pharmacology and Molecular Docking Integration Strategy.

Authors:  Qinqin Zhao; Bei Zheng; Pinpin Feng; Xiang Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-04       Impact factor: 2.629

Review 4.  Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms.

Authors:  Khanh vinh quốc Long; Lan Thi Hoàng Nguyễn
Journal:  Mol Brain       Date:  2013-04-09       Impact factor: 4.041

5.  Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis.

Authors:  Andrés Trostchansky; Mauricio Mastrogiovanni; Ernesto Miquel; Sebastián Rodríguez-Bottero; Laura Martínez-Palma; Patricia Cassina; Homero Rubbo
Journal:  Front Mol Neurosci       Date:  2018-04-30       Impact factor: 5.639

6.  Generation of Cellular Reactive Oxygen Species by Activation of the EP2 Receptor Contributes to Prostaglandin E2-Induced Cytotoxicity in Motor Neuron-Like NSC-34 Cells.

Authors:  Yasuhiro Kosuge; Hiroshi Nango; Hiroki Kasai; Takuya Yanagi; Takayuki Mawatari; Kenta Nishiyama; Hiroko Miyagishi; Kumiko Ishige; Yoshihisa Ito
Journal:  Oxid Med Cell Longev       Date:  2020-01-11       Impact factor: 6.543

7.  Bidens pilosa Extract Administered after Symptom Onset Attenuates Glial Activation, Improves Motor Performance, and Prolongs Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Yasuhiro Kosuge; Erina Kaneko; Hiroshi Nango; Hiroko Miyagishi; Kumiko Ishige; Yoshihisa Ito
Journal:  Oxid Med Cell Longev       Date:  2020-01-29       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.